Skyepharma Plc (SKYEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 29,380 | 41,470 | 45,160 | 39,020 |
| Marketable Securities | N/A | 2,090 | 1,750 | 3,150 | 0 |
| Receivables | N/A | 38,050 | 27,900 | 56,660 | 20,350 |
| Inventories | N/A | 2,930 | 2,350 | 2,020 | 3,300 |
| Other current assets | 0 | 20 | 10 | 20 | 10 |
| TOTAL | $N/A | $72,470 | $73,480 | $107,010 | $62,680 |
| Non-Current Assets | |||||
| PPE Net | N/A | 77,840 | 76,050 | 73,240 | 65,230 |
| Investments And Advances | 0 | 38,510 | 41,790 | 32,030 | 20,620 |
| Other Non-Current Assets | 0 | 175,340 | 169,700 | 160,980 | 142,550 |
| TOTAL | $N/A | $291,690 | $287,540 | $266,250 | $228,400 |
| Total Assets | $N/A | $364,180 | $361,030 | $373,270 | $291,090 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 18,720 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 0 | 46,910 | 70,170 | 31,220 | 51,060 |
| Other current liabilities | N/A | 27,380 | 0 | 24,250 | 0 |
| TOTAL | $N/A | $93,020 | $70,170 | $55,480 | $51,060 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 127,370 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 21,400 | 131,640 | 112,990 | 101,940 |
| TOTAL | $N/A | $149,240 | $136,900 | $117,750 | $101,940 |
| Total Liabilities | $N/A | $242,280 | $207,080 | $173,240 | $153,010 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,376 | N/A | N/A | N/A | N/A |
| Common Shares | N/A | 121,550 | 112,550 | 100,670 | 84,750 |
| Retained earnings | N/A | -632,550 | -544,970 | -424,930 | -392,640 |
| Other shareholders' equity | 0 | 17,910 | 16,690 | 14,980 | 30,940 |
| TOTAL | $N/A | $121,900 | $153,950 | $200,020 | $138,080 |
| Total Liabilities And Equity | $0 | $364,180 | $361,030 | $373,260 | $291,090 |